← The Wire
ARDXNasdaq
ARDELYX, INC.
Pharmaceutical Preparations · DE · CIK 1437402
Ardelyx develops and commercializes innovative medicines for unmet medical needs, including IBSRELA and XPHOZAH
red 8-K · 90d
$1.41B
Market cap
$5.23
Last close
-5.8%
1D
-17.9%
5D
9.0M
Volume
Price · last 39 sessions-28.4%
May 4L $5.23 · H $7.30Jun 29
228
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 17, 2026DEFA14ADEFA14AMay 26, 2026DEFA14ADEFA14AMay 19, 202610-Q10-QApr 30, 20268-KResults of Operations · Reg FD DisclosureApr 30, 2026DEF 14ADEF 14AApr 29, 202610-K10-KFeb 19, 20268-KResults of Operations · Reg FD DisclosureFeb 19, 20268-KResults of Operations · Company UpdateJan 8, 20268-KExecutive Change · Company UpdateDec 17, 202510-Q10-QOct 30, 20258-KResults of OperationsOct 30, 20258-KExecutive ChangeOct 14, 202510-Q10-QAug 4, 20258-KExecutive Change · Results of OperationsAug 4, 20258-KMaterial AgreementJul 3, 20258-KExecutive Change · Shareholder VoteJun 18, 202510-Q10-QMay 1, 20258-KResults of OperationsMay 1, 2025DEF 14ADEF 14AApr 30, 20258-KExecutive ChangeApr 29, 202510-K10-KFeb 20, 20258-KResults of OperationsFeb 20, 20258-KResults of Operations · Company UpdateJan 13, 20258-KExecutive ChangeNov 18, 202410-Q10-QOct 31, 20248-KResults of OperationsOct 31, 20248-KMaterial AgreementOct 9, 20248-KMaterial AgreementAug 12, 202410-Q10-QAug 1, 20248-KResults of OperationsAug 1, 20248-KCompany UpdateJul 2, 20248-KExecutive Change · Shareholder VoteJun 17, 2024DEFA14ADEFA14AJun 4, 20248-KCompany UpdateMay 23, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 2024DEF 14ADEF 14AApr 29, 20248-KNew Debt / ObligationMar 5, 202410-K10-KFeb 22, 20248-KResults of OperationsFeb 22, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GJan 26, 20248-KResults of OperationsJan 8, 20248-KExecutive ChangeNov 13, 202310-Q10-QOct 31, 20238-KResults of OperationsOct 31, 20238-KMaterial Agreement · New Debt / ObligationOct 18, 20238-KCompany UpdateOct 18, 20238-KCompany UpdateSep 25, 202310-Q10-QAug 2, 20238-KResults of OperationsAug 2, 2023SC 13GSC 13GJul 10, 20238-KBylaw Amendment · Shareholder VoteJun 20, 2023DEFA14ADEFA14AJun 5, 20238-KReg FD DisclosureMay 17, 202310-Q10-QMay 3, 20238-KResults of OperationsMay 3, 2023DEF 14AFORM DEF 14AApr 26, 202310-K10-KMar 2, 20238-KResults of OperationsMar 2, 20238-KMaterial Agreement · New Debt / ObligationFeb 15, 2023SC 13GSC 13GFeb 7, 20238-KMaterial AgreementJan 24, 20238-KCompany UpdateDec 29, 2022SC 13GSC 13GDec 2, 202210-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KCompany UpdateSep 19, 2022SC 13GSC 13GSep 12, 20228-KResults of OperationsAug 4, 202210-Q10-QAug 4, 20228-KShareholder VoteJul 15, 2022DEFA14ADEFA14AJul 1, 20228-KMaterial AgreementJun 30, 20228-KShareholder VoteJun 22, 2022DEFA14ADEFA14AJun 8, 20228-KDelisting NoticeMay 27, 202210-Q10-QMay 5, 20228-KResults of OperationsMay 5, 2022
Insider Activity
In the 90 days to Mar 16, 2026: 1 insider bought $1.9M · 8 sold $1.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Raab MichaelPresident & CEO | Sell | 41,666 | $5.84 | $243K |
| Feb 24, 2026 | Raab MichaelPresident & CEO | Sell | 41,666 | $6.26 | $261K |
| Feb 20, 2026 | Mott David MDirector | Buy | 333,333 | $5.84 | $1.9M |
| Feb 20, 2026 | Raab MichaelPresident & CEO | Sell | 40,401 | $5.87 | $237K |
| Feb 20, 2026 | Foster Eric DuaneChief Commercial Officer | Sell | 9,176 | $5.87 | $54K |
| Feb 20, 2026 | Kelliher MikeSee Remarks | Sell | 8,434 | $5.87 | $50K |
| Feb 20, 2026 | Williams Laura ASee Remarks | Sell | 7,192 | $5.87 | $42K |
| Feb 20, 2026 | Raab MichaelPresident & CEO | Sell | 5,576 | $5.71 | $32K |
| Feb 20, 2026 | Reilly Joseph JamesSee Remarks | Sell | 4,387 | $5.87 | $26K |
| Feb 20, 2026 | Bishop John ESee Remarks | Sell | 2,792 | $5.87 | $16K |
| Feb 20, 2026 | Brady James ParkerChief Human Resources Officer | Sell | 2,234 | $5.87 | $13K |
| Feb 20, 2026 | Hohenleitner SusanChief Financial Officer | Sell | 1,786 | $5.87 | $10K |
| Feb 20, 2026 | Foster Eric DuaneChief Commercial Officer | Sell | 1,261 | $5.71 | $7K |
| Feb 20, 2026 | Kelliher MikeSee Remarks | Sell | 1,159 | $5.71 | $7K |
| Feb 20, 2026 | Williams Laura ASee Remarks | Sell | 984 | $5.71 | $6K |
| Feb 20, 2026 | Reilly Joseph JamesSee Remarks | Sell | 602 | $5.71 | $3K |
| Feb 20, 2026 | Bishop John ESee Remarks | Sell | 386 | $5.71 | $2K |
| Feb 20, 2026 | Brady James ParkerChief Human Resources Officer | Sell | 309 | $5.71 | $2K |
| Feb 20, 2026 | Hohenleitner SusanChief Financial Officer | Sell | 247 | $5.71 | $1K |
| Feb 20, 2026 | Kelliher MikeSee Remarks | Sell | 2 | $5.71 | $11 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance